YMI Marketing Campaign Update

0

Calgary, AB – TheNewswire – November 16, 2022 nDatalyze Corp. (“NDAT“or the”society”) (CSE:NDAT) (OTC:NDATF) is pleased to announce that the Company’s marketing contractor, BelieveCo (formerly VenturePlay), has provided an interim update on the progress of the YMI marketing campaign (the “Campaign”). BelieveCo reports that after just one month, “the media campaign performed incredibly well” and “the data shows that our performance is well above benchmarks.”

“on-site behavior” tracking to provide valuable insights into pre-purchase behaviors during the purchase process. We will now incorporate this knowledge into Phase 2 and increase the resolution of our behavioral data collection to optimize the overall buying process.”

In the short term, the Society plans to expand the campaign by:

a) contracting social media influencers – relevant influencers have been identified and awareness raising has begun;

b) incorporation of social media “boosts” – which should begin before November 30, 2022;

c) increase in digital ad spend – expected before end of November 2022; and

d) expand the target geography to include all of Canada – expected before December 15, 2022.

The Company further reports that an introductory price reduction took place during Phase 1 and that the small number of sales that occurred prior to the price reduction were refunded as a gesture of goodwill to these customers. – which means that customers before the reduction effectively had access to YMI for free. The refunds will not have a material impact on the Company’s financial statements. The Campaign is fully funded by the Company’s existing cash balance.

YMI is available now at https://ymihealth.ca/

About nDatalyze Corp. :

nDatalyze Corp. generates technological solutions related to health. The YMI division has developed a machine learning-based online mental health application based on the company’s proprietary reference database consisting of over 1200 complete biometric records with associated electroencephalogram (“EEG”) The data. With facilities around the world, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI was only recently launched and therefore the Company cannot accurately predict if or when this application will become a cash flow generator.

FOR MORE INFORMATION, PLEASE CONTACT:

nDatalyze Corp.

James Durward, President and CEO

Phone: (403) 689-3901

E-mail: [email protected] Website: www.ndatalyze.com

Investor Relations

RBMG – RB Milestone Group LLC

[email protected]

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer to sell or a solicitation of an offer to sell any securities in the United States. The Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “United States Securities Act”) or any state securities law and may not be offered or sold in the United States or to US persons unless registered under United States securities law and applicable state securities laws or an exemption from such registration is available.

The information in this press release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based on assumptions subject to significant risks and uncertainties. Due to these risks and uncertainties and due to various factors, actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. A number of factors could cause actual results to differ materially from these forward-looking statements and from future results. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the expectations in the forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and undertakes no obligation to update or revise forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting these forward-looking or other statements.

Share.

Comments are closed.